Literature DB >> 6872098

Assessment of membrane damage in continuous cultures of mammalian cells.

J K Malik, L R Schwarz, F J Wiebel.   

Abstract

The present studies were aimed at evaluating procedures for assessing the effect of chemicals on the integrity of the plasma membrane in continuous cell cultures. The degree of membrane damage was monitored by determining the 'leakage' of alpha-[3H]aminoisobutyric acid ([3H]AIB) and [14C]deoxy-2-fluoro-D-glucose ([14C]FdG) from the prelabelled cells. These parameters were compared to the loss of lactate dehydrogenase (LDH) from the cells and the decrease in the intracellular level of K+. Triton X-100, sodium dodecylsulfate (SDS), phospholipase C and nystatin which are known to affect membranes by different mechanisms served as test agents. In parallel, we monitored the effects of the chemicals on the viability of the cells. The following results were obtained: (1) The two radioactive markers [3H]AIB and [14C]FdG were found to be suitable to probe for damages of the plasma membrane in a variety of continuous cell lines which differ widely in their phenotype, rate of growth and degree of differentiation. (2) The leakage of the two markers could conveniently be monitored by double labelling techniques. (3) The loss from the cells of the 3 markers of smaller molecular size, K+, [3H]AIB, [14C]FdG, differed considerably depending on the test agent used. (4) Intracellular K+ level and [3H]AIB leakage generally appeared to follow a similar pattern, whereas [14C]FdG leakage may have shown a distinctly different response. (5) The leakage of LDH was an insensitive indicator for membrane damage. (6) No clear relationship was detectable between a particular leakage pattern of the markers and the loss of cellular viability.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872098     DOI: 10.1016/0009-2797(83)90040-6

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  1 in total

1.  Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.

Authors:  Esther Fernández-Simón; Cinta Lleixà; Xavier Suarez-Calvet; Jordi Diaz-Manera; Isabel Illa; Eduard Gallardo; Noemí de Luna
Journal:  BMC Musculoskelet Disord       Date:  2020-11-27       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.